Evaluation of the prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbation of chronic obstructive pulmonary disease
- PMID: 36092488
- PMCID: PMC9450251
- DOI: 10.4103/jrms.JRMS_512_20
Evaluation of the prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbation of chronic obstructive pulmonary disease
Abstract
Background: The present study aimed at determining and comparing the prognostic value and the relationship of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios (PLRs) with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
Materials and methods: The present case-control study was performed on 100 chronic obstructive pulmonary disease patients and 100 healthy subjects (controls). Age, gender, and laboratory results of complete blood count tests including lymphocyte count, neutrophil count, platelet count, hemoglobin level, neutrophil-to-lymphocyte ratio (NLR), PLR, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were obtained from the patient report and then recorded. The mentioned information was also completed for the control group. Following hospitalization, the patients that were discharged with clinically stable general status were re-examined, and the aforementioned laboratory information was rerecorded.
Results: The results of the present study revealed that NLR with the sensitivity and specificity of 83.00% (74.2%-89.8%) and 93.00% (86.1%-97.1%) (cutoff value of 2.3), PLR with the sensitivity and specificity of 56.00% (46.0%-66.3%) and 83.00% (74.2%-89.8%) (cutoff value of 135.8), white blood cell (WBC) with the sensitivity and specificity of 69.00% (57.7%-77.8%) and 78.00% (68.6%-85.7%) (cutoff value of 8.5 × 103 μl), ESR with the sensitivity and specificity of 84.00% (75.3%-90.6%) and 99.00% (94.6%-100.0%) (cutoff value of 7.8), and CRP with the sensitivity and specificity of 52.00% (41.8%-62.1%) and 81.00% (71.9%-88.2%) (cutoff value of 1.9), respectively, had a significant prognostic value of AECOPD (P < 0.001). In addition to NLR had higher area under the curve (AUC) than PLR, WBC, and CRP. Therefore NLR had a better diagnostic value than the above three markers (P < 0.001). ESR also has higher AUC levels compared to PLR, WBC, and CRP and has a statistically better diagnostic value than them (P < 0.001), but did not differ significantly from ESR (difference between AUC: 0.02; P = 0.059).
Conclusion: According to the results of the current study, NLR and PLR had a significant direct relationship with the two main markers of ESR and CRP, and both ratios had a significant prognostic value in AECOPD.
Keywords: Blood platelets; chronic obstructive pulmonary disease; lymphocytes; neutrophils.
Copyright: © 2022 Journal of Research in Medical Sciences.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.Int J Chron Obstruct Pulmon Dis. 2017 Aug 3;12:2285-2290. doi: 10.2147/COPD.S141760. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28814856 Free PMC article.
-
Evaluation of the relationship of neutrophil-to lymphocyte ratio and platelet-to-lymphocyte ratio with in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease.Clin Respir J. 2021 Apr;15(4):382-388. doi: 10.1111/crj.13312. Epub 2020 Dec 1. Clin Respir J. 2021. PMID: 33210811
-
Prognostic Value of Neutrophil:Lymphocyte and Platelet:Lymphocyte Ratios for 28-Day Mortality of Patients with AECOPD.Int J Gen Med. 2021 Jun 25;14:2839-2848. doi: 10.2147/IJGM.S312045. eCollection 2021. Int J Gen Med. 2021. PMID: 34211292 Free PMC article.
-
Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients.Expert Rev Respir Med. 2020 Jan;14(1):111-116. doi: 10.1080/17476348.2019.1675517. Epub 2019 Oct 13. Expert Rev Respir Med. 2020. PMID: 31577911 Review.
-
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future.Eur Respir Rev. 2022 Nov 2;31(166):220095. doi: 10.1183/16000617.0095-2022. Print 2022 Dec 31. Eur Respir Rev. 2022. PMID: 36323421 Free PMC article. Review.
Cited by
-
The Impact of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).J Clin Med. 2023 Jan 31;12(3):1100. doi: 10.3390/jcm12031100. J Clin Med. 2023. PMID: 36769748 Free PMC article.
References
-
- Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195:557–82. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous